NPI: 1629005558 · LEAWOOD, KS 66211 · Clinical Social Worker · NPI assigned 06/27/2006
Authorized official PINCINCE, DEBORAH controls 20+ related entities in our dataset. Read more
| Authorized Official | PINCINCE, DEBORAH (ADMINISTRATOR) |
| NPI Enumeration Date | 06/27/2006 |
Other providers sharing the same authorized official: PINCINCE, DEBORAH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,787 | $231K |
| 2019 | 1,963 | $93K |
| 2020 | 7,363 | $119K |
| 2021 | 30,140 | $662K |
| 2022 | 16,998 | $335K |
| 2023 | 11,155 | $388K |
| 2024 | 7,078 | $292K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 15,188 | 13,713 | $457K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 5,906 | 5,781 | $400K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6,941 | 6,501 | $390K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 26,784 | 24,153 | $319K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3,775 | 3,467 | $227K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 7,581 | 7,141 | $99K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1,816 | 1,692 | $80K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3,333 | 3,203 | $32K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2,954 | 1,311 | $26K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 816 | 751 | $23K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,301 | 1,278 | $20K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 192 | 180 | $19K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,011 | 984 | $12K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 146 | 145 | $6K |
| 86580 | 980 | 903 | $6K | |
| 90480 | 115 | 114 | $3K | |
| 81002 | 407 | 387 | $1K | |
| 99201 | 42 | 42 | $1K | |
| 90674 | 14 | 14 | $120.00 | |
| 1159F | 477 | 431 | $0.00 | |
| 1160F | 488 | 445 | $0.00 | |
| 3078F | 175 | 154 | $0.00 | |
| 3008F | 202 | 181 | $0.00 | |
| 3074F | 230 | 207 | $0.00 | |
| 1036F | 610 | 550 | $0.00 |